Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Jeffrey F. Barletta"'
Autor:
Jeffrey F. Barletta, Brian L. Erstad
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-8 (2022)
Abstract Obesity is highly prevalent in hospitalized patients admitted with COVID-19. Evidence based guidelines are available for COVID-19-related therapies but dosing information specific to patients with obesity is lacking. Failure to account for t
Externí odkaz:
https://doaj.org/article/06296bd450d84727b36818b8d09199e2
Autor:
Brian L. Erstad, Jeffrey F. Barletta
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-8 (2021)
Abstract Medications used for supportive care or prophylaxis constitute a significant portion of drug utilization in the intensive care unit. Evidence-based guidelines are available for many aspects of supportive care but drug doses listed are typica
Externí odkaz:
https://doaj.org/article/9597ea7dbb0b43d9b4337e7084be6559
Autor:
Brian L. Erstad, Jeffrey F. Barletta
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-8 (2020)
Abstract Practice guidelines provide clear evidence-based recommendations for the use of drug therapy to manage pain, agitation, and delirium associated with critical illness. Dosing recommendations however are often based on strategies used in patie
Externí odkaz:
https://doaj.org/article/4fbf91cc5b4d4fec8a84d0a572daee97
Autor:
Alicia Mangram, Kimberli Bruce, Joseph F Sucher, Nuria Blake, Charles D Balcome, Laura Prokuski, James Dzandu, Jeffrey F Barletta, Gina R Shirah
Publikováno v:
Trauma Surgery & Acute Care Open, Vol 9, Iss 1 (2024)
Background The transfusion threshold for low hemoglobin (Hgb) in geriatric patients with hip fractures is widely debated. In certain populations, low Hgb is associated with poor outcomes. Our objective was to evaluate the relationship between lowest
Externí odkaz:
https://doaj.org/article/f5d4a72addaa432ebe4968b1796a07af
Autor:
Jeffrey F. Barletta
Publikováno v:
Current Opinion in Clinical Nutrition & Metabolic Care. 26:174-178
Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme Obesity
Autor:
Brian L. Erstad, Jeffrey F. Barletta
Publikováno v:
Annals of Pharmacotherapy. 57:727-737
Objective: The objective of the study was to discuss the controversies surrounding the use and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the limitations of the existing evidence base that preclude strong recomm
Publikováno v:
American Journal of Health-System Pharmacy. 80:87-91
Challenges With Using a Weight-Based Approach to Bolus Fluid Dosing in Obese Critically Ill Patients
Autor:
Brian L. Erstad, Jeffrey F. Barletta
Publikováno v:
Annals of Pharmacotherapy. 57:609-616
At least 30 mL/kg of crystalloid fluid administration within the first 3 hours of resuscitation is suggested by the current Surviving Sepsis Campaign guidelines for management of sepsis and septic shock. This commentary discusses the challenges with
Publikováno v:
World Journal of Surgery. 46:98-103
Ketorolac is an effective analgesic but the potential for acute kidney injury (AKI) is concerning, particularly in geriatric “G-60 trauma” patients. The objectives of this study are to report the incidence of AKI in patients who receive ketorolac
Autor:
Brian L Erstad, Jeffrey F Barletta
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author p